Ticker Details
EyePoint Pharmaceuticals, Inc. Common Stock
IPO Date:	February 1, 2005
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.19B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 3.74%
Avg Daily Range (30 D):	$0.42 | 2.85%
Avg Daily Range (90 D):	$0.51 | 3.35%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	1.01M
Avg Daily Volume (90 D):	1.06M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	997
Avg Institutional Trade:	$1.6M
Avg Institutional Trade (30 D):	$1.82M
Avg Institutional Trade (90 D):	$1.87M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.72M
Avg Closing Trade (30 D):	$2.63M
Avg Closing Trade (90 D):	$2.57M
Avg Closing Volume:	129.87K

News

Mar 16, 2026 @ 10:23 PM This Biotech Stock Up 700% Is Still a Top Holding ... Source: Jonathan Ponciano

Mar 16, 2026 @ 11:00 AM EyePoint Reports Inducement Grants Under NASDAQ Li... Source: Na

Mar 15, 2026 @ 11:05 PM This Biotech Stock Up Nearly 100% in a Year Has Dr... Source: Jonathan Ponciano

Feb 25, 2026 @ 12:00 PM EyePoint to Report Fourth Quarter and Full-Year 20... Source: Not Specified

Feb 18, 2026 @ 12:00 PM EyePoint Appoints Michael Campbell as Chief Commer... Source: Eyepoint, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.17	$-.82	$-3.17
Diluted EPS	$-3.17	$-.82	$-3.17
Revenue	$31.37M	$.62M	$31.37M
Gross Profit
Net Income / Loss	$-231.96M	$-67.61M	$-231.96M
Operating Income / Loss	$-243.43M	$-70.35M	$-243.43M
Cost of Revenue
Net Cash Flow	$2.12M	$27.24M	$2.12M
PE Ratio

Splits
Dec 09, 2020	1:10
Jun 11, 2008	1:4